First Eagle Investment Management, LLC Halozyme Therapeutics, Inc. Transaction History

First Eagle Investment Management, LLC

$48.1 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$25.81 - $43.62 $12.5 Million - $21.1 Million	-483,800 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$25.74 - $29.63 $26.6 Million - $30.6 Million	-1,033,827 Reduced 68.12%	483,800 $12.7 Million
Q2 2020 Aug 10, 2020	SELL	$16.25 - $26.81 $1.07 Million - $1.77 Million	-66,048 Reduced 4.17%	1,517,627 $40.7 Million
Q1 2020 May 12, 2020	SELL	$13.9 - $21.83 $733,920 - $1.15 Million	-52,800 Reduced 3.23%	1,583,675 $28.5 Million
Q4 2019 Feb 10, 2020	SELL	$14.93 - $19.53 $14,930 - $19,530	-1,000 Reduced 0.06%	1,636,475 $29 Million
Q3 2019 Nov 12, 2019	SELL	$15.2 - $17.69 $893,760 - $1.04 Million	-58,800 Reduced 3.47%	1,637,475 $25.4 Million
Q2 2019 Aug 13, 2019	SELL	$14.75 - $17.26 $6.37 Million - $7.46 Million	-432,000 Reduced 20.3%	1,696,275 $29.1 Million
Q1 2019 May 13, 2019	SELL	$13.94 - $17.58 $34,850 - $43,949	-2,500 Reduced 0.12%	2,128,275 $34.3 Million
Q4 2018 Feb 11, 2019	SELL	$13.33 - $18.66 $564,045 - $789,579	-42,314 Reduced 1.95%	2,130,775 $31.2 Million
Q3 2018 Nov 13, 2018	BUY	$16.68 - $18.41 $809,413 - $893,363	48,526 Added 2.28%	2,173,089 $39.5 Million
Q2 2018 Aug 13, 2018	SELL	$16.87 - $20.3 $14.8 Million - $17.9 Million	-880,190 Reduced 29.29%	2,124,563 $35.8 Million
Q1 2018 May 04, 2018	SELL	$17.06 - $21.2 $26 Million - $32.4 Million	-1,526,328 Reduced 33.69%	3,004,753 $58.9 Million
Q4 2017 Feb 05, 2018	SELL	$16.75 - $20.8 $32.1 Million - $39.8 Million	-1,913,900 Reduced 29.7%	4,531,081 $91.8 Million
Q3 2017 Nov 06, 2017	BUY	$11.76 - $17.4 $75.8 Million - $112 Million	6,444,981	6,444,981 $112 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Eagle Investment Management, LLC with notifications on news.

Account